vimarsana.com
Home
Live Updates
Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder : vimarsana.com
Optimi Health, ATMA Sign Letter of Intent To Advance Phase II Clinical Trial Group and Individual Administration Protocol For Major Depressive Disorder
VANCOUVER, British Columbia, May 22, 2024 -- Optimi Health Corp. , a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as...
Related Keywords
Vancouver ,
British Columbia ,
Canada ,
United Kingdom ,
United States ,
America ,
Canadian ,
British ,
Michael Kydd ,
Vu Tran ,
European Union ,
Group Therapy ,
Neither The Canadian Securities Exchange ,
Optimi Health Canada ,
Health Canada ,
Investment Industry Regulatory Organization Of Canada ,
Journey Centers ,
Optimi Health Corp ,
Psilocybin Clinical Trial ,
Individual Set ,
Major Depressive Disorder ,
North America ,
Bill Ciprick ,
Compass Pathways ,
Mind Med ,
Lykos Therapeutics ,
Canadian Securities Exchange ,
Investment Industry Regulatory Organization ,
vimarsana.com © 2020. All Rights Reserved.